WilmerHale Reps Thermo Fisher In $3.5B Phadia Buy

Law360, New York (May 19, 2011, 12:11 PM EDT) -- Fresh off completing its purchase of Dionex Corp., Thermo Fisher Scientific Inc. said Thursday it would snap up Swedish allergy and autoimmunity diagnostics company Phadia AB for $3.5 billion in cash to supercharge its go-global strategy.

The latest purchase came one day after the Waltham, Mass.-based science industry giant said it would buy Sterilin Ltd., a U.K.-based provider of single-use plastic products serving microbiology, life sciences and clinical customers, for an undisclosed sum.

The Phadia buy came just two days after Thermo Fisher finally secured its...
To view the full article, register now.